JUVENESCENCE Appoints Dr Richard Marshall CBE as CEO
16 Jan 2023 //
BUSINESSWIRE
Juvenescence, The Buck Institute for Research on Aging launch Selah Therapeutics
11 May 2022 //
PRNEWSWIRE
Juvenescence Announces Licensing Agreement with Evgen Pharma plc
15 Sep 2020 //
BUSINESSNEWS WIRE